Useful links
Unit of study_
SURG5038: Malignant Breast Disease and MDTs
2024 unit information
Breast surgery requires a thorough knowledge of the science and management of malignant breast disease and this unit of study aims to prepare the post fellowship candidate for a career in breast surgery. The content focuses on the pathology and recent advances in the understanding of the pathogenesis of malignant breast disease. You will gain an indepth understanding of available prognostic assessment tools, multidisciplinary care of breast cancer patients ( including adjuvant and neoadjuvant chemotherapy, radiotherapy, endocrine therapy and the integral role of the breast care nurse and other allied health staff) and survivorship issues. Specific surgical decision algorithms and surgical options for malignant and insitu disease will be thoroughly explored and explained.
Unit details and rules
Managing faculty or University school:
Surgery
| Code | SURG5038 |
|---|---|
| Academic unit | Surgery |
| Credit points | 6 |
|
Prerequisites:
?
|
SURG5037 |
|---|---|
|
Corequisites:
?
|
None |
| Prohibitions:
?
|
None |
| Assumed knowledge:
?
|
This unit is designed as the first part of a curriculum for contemporary breast surgery for Post Fellowship Trainees and assumes practical skills training is obtained on the BreastSurgANZ PFT Program (or equivalent). Applicants must have completed general or plastic surgical training and have a strong interest in breast surgery |
At the completion of this unit, you should be able to:
- LO1. understand the different histopathology subtypes and prognostic implications of each across the spectrum of breast malignancy
- LO2. understand the subtleties of management associated with the different subtypes of breast malignancy
- LO3. demonstrate a comprehensive understanding of and ability to meaningfully contribute to the interactions and recommendations of the multidisciplinary team for your patients’ optimal breast cancer management
- LO4. demonstrate a solid understanding of the neoadjuvant and adjuvant systemic therapy options
- LO5. demonstrate a solid and contemporary understanding of adjuvant (and neoadjuvant) radiotherapy options
- LO6. understand treatment related toxicity and morbidity and how it is best managed
- LO7. understand the principles of management of locally advanced and breast cancer recurrence
- LO8. understand the importance of breast care nurse, supportive care, and psycho-oncological colleagues to maximise patient acceptance, tolerance, compliance and quality of life during and after treatment
- LO9. be aware of evolving management trends, contemporary clinical trials and unresolved management questions for patients with breast malignancy.
Unit availability
This section lists the session, attendance modes and locations the unit is available in. There is a unit outline for each of the unit availabilities, which gives you information about the unit including assessment details and a schedule of weekly activities.
The outline is published 2 weeks before the first day of teaching. You can look at previous outlines for a guide to the details of a unit.
| Session | MoA ? | Location | Outline ? |
|---|---|---|---|
|
Semester 2 2024
|
Online | Camperdown/Darlington, Sydney |
Outline unavailable
|
Modes of attendance (MoA)
This refers to the Mode of attendance (MoA) for the unit as it appears when you’re selecting your units in Sydney Student. Find more information about modes of attendance on our website.
